Thus, endothelial cells carrying HLA-A*02 and LMP2 60HH might lead to a decreased BBB crossing by MBP-reactive CD8+ T cells during the early phases of neuroinflammation, affecting MS development. This evidence concerns the gene PSMB9 and myeloid sarcoma.